BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.
Two new studies identify potential warning signs of cognitive decline in older adults
By
John Roszkowski
Oct 13, 2023
Older adults who show subtle decline on standard memory and cognitive tests may be at increased risk for developing mild cognitive impairment, a precursor to dementia, according to the results of a new...
Medicare’s plan to cover Alzheimer’s drugs hinges on patient data registries
By
Alicia Lasek
Jun 02, 2023
Medicare Part B will cover Alzheimer’s drugs with traditional FDA approval, CMS announced Thursday. Prescribing clinicians must participate in a patient data registry.
Adapted for all
By
Kimberly Marselas
May 01, 2014
Senior living spaces are sprouting up with accommodations for residents with a vast array of physical, developmental and other needs to make them comfortable